ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Small Pharma Inc

Small Pharma Inc (DMT)

0.15
0.00
( 0.00% )
Actualizado: 18:00:00

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
0.15
Postura de Compra
0.19
Postura de Venta
0.19
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.15 Rango de 52 semanas 0.15
Capitalización de Mercado [m]
Precio Anterior
0.15
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
321,562,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.11
Beneficio por acción (BPA)
-0.07
turnover
-
Beneficio neto
-22.84M

Acerca de Small Pharma Inc

Sector
Pension,health,welfare Funds
Industria
Pension,health,welfare Funds
Sede
London, Gbr
Fundado
-
Small Pharma Inc is listed in the Pension,health,welfare Funds sector of the TSX Venture Exchange with ticker DMT. The last closing price for Small Pharma was $0.15. Over the last year, Small Pharma shares have traded in a share price range of $ 0.15 to $ 0.15.

Small Pharma currently has 321,562,000 shares in issue. The market capitalisation of Small Pharma is $48.23 million. Small Pharma has a price to earnings ratio (PE ratio) of -2.11.

DMT Últimas noticias

Cybin Completes Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic Therapeutics

This news release constitutes a “designated news release” for the purposes of Cybin’s prospectus supplements each dated August 23, 2023, to its short form base shelf prospectus dated August 17...

Small Pharma Reports Fiscal Second Quarter 2024 Highlights

• Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma, supporting the combined company’s vision to build an international clinical-stage leader in psychedelic-based...

Small Pharma Obtains Final Order Approving Arrangement

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (“Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions and Cybin Inc. (NYSE...

Small Pharma Announces Voting Results from Annual General and Special Meeting of Shareholders

• Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma LONDON, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or...

Disposition of Common Shares of Small Pharma Inc.

LONDON, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Mr. Peter Rands disposed of an aggregate of 1,532,001 common shares in the capital of Small Pharma Inc. (the “Company”) between September 25, 2023 and...

Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder

• Results suggest that SSRIs enhance the efficacy of SPL026 (DMT) when administered to MDD patients on a stable dose of SSRIs versus patients not on SSRIs • At Week 4, 100% of patients in the...

Cybin übernimmt Small Pharma Inc.

- Durch den Erwerb sämtlicher Aktien wird ein international führendes Unternehmen für neuartige psychedelische Therapeutika in der klinischen Phase geschaffen - - Es befinden sich zwei...

Cybin to Acquire Small Pharma Inc.

- All-share transaction creates international clinical-stage leader in novel psychedelic therapeutics - - Two proprietary, advanced clinical programs in development for depression and anxiety...

Small Pharma Reports Fiscal First Quarter 2024 Highlights

• Last patient dosed in SPL026-SSRI drug interaction study with data readout anticipated in Q3 2023 • Potential for an expedited route to an international, multi-site Phase II study with SPL028 in...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.150.150.1500CS
4000.150.150.1500CS
12000.150.150.1500CS
26000.150.150.1500CS
52000.150.150.1500CS
156-0.095-38.77551020410.2450.3950.061172680.13600722CS
260-0.85-8511.10.061158080.1865532CS

DMT - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Small Pharma?
El precio actual de las acciones de Small Pharma es $ 0.15
¿Cuántas acciones de Small Pharma están en circulación?
Small Pharma tiene 321,562,000 acciones en circulación
¿Cuál es la capitalización de mercado de Small Pharma?
La capitalización de mercado de Small Pharma es CAD 48.23M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Small Pharma?
Small Pharma ha negociado en un rango de $ 0.15 a $ 0.15 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Small Pharma?
El ratio precio/beneficio de Small Pharma es -2.11
¿Cuál es la moneda de reporte de Small Pharma?
Small Pharma presenta sus resultados financieros en CAD
¿Cuál es el último beneficio anual de Small Pharma?
El último beneficio anual de Small Pharma es CAD -22.84M
¿Cuál es la dirección registrada de Small Pharma?
La dirección registrada de Small Pharma es 6-8 BONHILL STREET, 3RD FLOOR, LONDON, EC2A 4BX
¿Cuál es la dirección del sitio web de Small Pharma?
La dirección del sitio web de Small Pharma es www.smallpharma.com
¿En qué sector industrial opera Small Pharma?
Small Pharma opera en el sector PENSION,HEALTH,WELFARE FUNDS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CTGCentenario Gold Corp
$ 0.02
(100.00%)
650.1k
TKUTarku Resources Ltd
$ 0.015
(50.00%)
94k
TOHTotal Helium Ltd
$ 0.015
(50.00%)
3k
KSKlondike Silver Corp
$ 0.015
(50.00%)
118.33k
ENRGNew Energy Metals Corp
$ 0.325
(47.73%)
500
TVITVI Pacific Inc
$ 0.005
(-50.00%)
20k
MNLXMiniluxe Holding Corp
$ 0.465
(-38.00%)
4.4k
MTLOMartello Technologies Group Inc
$ 0.01
(-33.33%)
22k
PGDCPatagonia Gold Corp
$ 0.035
(-30.00%)
36.3k
QGRQ Gold Resources Ltd
$ 0.08
(-27.27%)
55.85k
XBOTRealbotix Corp
$ 0.68
(11.48%)
6.13M
QNCQuantum Emotion Corp
$ 0.72
(-20.00%)
3.54M
WWTWater Ways Technologies Inc
$ 0.005
(0.00%)
2.1M
GPUSAlset AI Ventures Inc
$ 0.17
(-8.11%)
1.46M
THRMTherma Bright Inc
$ 0.045
(12.50%)
1.36M
martyDg martyDg 49 segundos hace
In a few weeks? What facts are you even talking about? Nobody here, not even the management, has any idea when the decision is coming. It’s already been a year! Are you seriously going to keep saying we’re weeks closer if, after two years, there’s still no decision? Don’t even start with the nonsens
NWBO
linkvest linkvest 50 segundos hace
https://eranb1.sg-host.com/
ASII
Trooperstocks Trooperstocks 1 minuto hace
Our Technology
SGTM uses disruptive technologies to transform biological waste into highly nutrient-rich products that impact both health and the environment!
SGTM
OnlyCredibleFactsMatter OnlyCredibleFactsMatter 1 minuto hace
You must not have been in the right stocks that went up significantly in 21 then. And have not looked at the charts that did. Saying that OTC did nothing in 21 is not true.
SRMX
glenn1919 glenn1919 1 minuto hace
zbia....................................https://stockcharts.com/h-sc/ui?s=zbia&p=W&b=5&g=0&id=p86431144783
ZBAI
FeMike FeMike 2 minutos hace
Yes indeed and with a revenue of $4 billion in the near future (within 1 to 2 years) an MC of almost $100 billion.

That you can't understand the absolute impossibility of this scenario shows me the type of person I am dealing with.

A market cap of $35 billion on approva
NWBO
Steady_T Steady_T 2 minutos hace
That same thought occurred to me as I read that P3 P4 sentence.
Perhaps he was referring to AD as P4 and other indications P3 trials... Using the dosing lessons learned. Transferring that learning to other trials makes sense.

I did notice that night time dosing was not mention
AVXL
haha11 haha11 3 minutos hace
$SPX.. ..15...2Ds......DLY trend LL...Needed trend HH...1/13/205

https://schrts.co/fUWXmwaj
SPX
JusDePomme JusDePomme 3 minutos hace
AFFU volume in let's go
AFFU
getmoreshares getmoreshares 3 minutos hace
Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT), today announced that it has entered into securities purchase agreements with several institutional investors to purchase an aggregate of 77,989,800 Ordinary Shares (the “Ordinary Shares”) in a registered dire
BHAT
JB51 JB51 3 minutos hace
Just need patience with them, report wasn't that bad, broke even, doing good things, just need federal government to approve pot and will rocket higher 
TLRY
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 3 minutos hace
AEXAY~~.0025, was $1.16,About Atos

Atos is a global leader in digital transformation with c. 82,000 employees and annual revenue of c. € 10 billion. European number one in cybersecurity, cloud and high-performance computing, the Group provides tailored end-to-end solutions for all ind
AEXAY
georgie18 georgie18 3 minutos hace
SGLY...$2.34...HOD...🥳...Beauty bounce...

georgie18

Member Level
Re: georgie18 post# 122

Saturday, January 11, 2025 3:52:43 PM

Post#
125
of 125
SGLY...$2.18...🥳... Bullish Harami Reversal Patte
SGLY
DewDiligence DewDiligence 3 minutos hace
Kailera/Hengrui phase-2 obesity data:

https://www.globenewswire.com/news-release/2025/01/13/3008465/0/en/Jiangsu-Hengrui-Pharmaceuticals-and-Kailera-Therapeutics-Report-Positive-Topline-Data-from-8-mg-Dose-of-Phase-2-Obesity-Trial-of-GLP-1-GIP-Receptor-Dual-Agonist-HRS9531.html
GLP
georgie18 georgie18 3 minutos hace
SGLY...$2.34...HOD...🥳...Beauty bounce...

georgie18

Member Level
Re: georgie18 post# 122

Saturday, January 11, 2025 3:52:43 PM

Post#
125
of 125
SGLY...$2.18...🥳... Bullish Harami Reversal Patte
SGLY
dexprs dexprs 3 minutos hace
Abercrombie & Fitch Increases Q4 Net Sales Growth Outlook To 7% - 8% From Prior Range Of 5% - 7%; FY24 Net Sales Of Around 15% Vs. Prior Range Of 14% - 15%
BENZINGA 7:15 AM ET 1/13/2025
"In 2025, we will look to continue sustainable, profitable growth through the execution of our play
Tiger Money Tiger Money 3 minutos hace
Got it 
KULR
georgie18 georgie18 3 minutos hace
SGLY...$2.34...HOD...🥳...Beauty bounce...

georgie18

Member Level
Re: georgie18 post# 122

Saturday, January 11, 2025 3:52:43 PM

Post#
125
of 125
SGLY...$2.18...🥳... Bullish Harami Reversal Patte
SGLY
thttlpckg thttlpckg 4 minutos hace
If appeal fails, won't they owe right away? Doubt plaintiff will wait for IPIX to succeed/fail.
IPIX
StockItOut StockItOut 4 minutos hace
True, yet how do you know that they are not BMXI's workers? Nils shaking hands with one mine worker.

I would have thought you'd have caught, that: all the trucks hauling ore within and from a huge pit mine, as the looping video of Brookmount Gold's website's central home page... that
BMXI
gdog gdog 4 minutos hace
huge mistake on my part on this one, don't usually make this kind of blunder at any rate now becoming a long hold.. southern California eletic company...
trading.jeff trading.jeff 4 minutos hace
$OXY uptrend is like a moonshot from the time Berkshire Hathaway averaged down in December. 🌙🚀
OXY
Dawgpound1 Dawgpound1 4 minutos hace
. 25 and dollar estimates and we can't even hold 3 cents you guys are delusional lmfao
CEOS
KILLAZILLA KILLAZILLA 5 minutos hace
you UNDERSTAND NOTHING ABOUT PATENT LAW!!!!

MAKES you AN IMBECILE!!!

EVEN IF xeri WASN'T A COMPLETE SCAM, WHICH WE ALL KNOW IT IS. they STILL CAN'T INFRINGE...

xeri IS TIED UP IN LAWSUITS. they DEFAULTED ON LOANS AND HAVE MASSIVE DEBT BECAUSE OF IT. they
XERI